Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GoodRx HoldingsGDRX -1.34%70 FCF Margin % is 33.14% as of Jun. 2026, which is 113% above its 10-year median of 15.54. GuruFocus rates GDRX with a GF Score™ of 70/100 and a GF Value™ of $5.29 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 666 Healthcare Providers & Services companies, GoodRx Holdings ranks better than 89.94% on this metric.
The historical rank and industry rank for GoodRx Holdings's FCF Margin % or its related term are showing as below:
GDRX'
s FCF Margin % Range Over the Past 10 Years
Min: 11 Med: 15.54 Max: 19.97
Current: 16.77
During the past 8 years, the highest FCF Margin % of GoodRx Holdings was 19.97%. The lowest was 11.00%. And the median was 15.54%.
GDRX's FCF Margin % is ranked better than 89.94% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 3.025
vs GDRX: 16.77
The historical data trend for GoodRx Holdings's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, GoodRx Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GoodRx Holdings FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, GoodRx Holdings's FCF Margin % distribution charts can be found below:
* The bar in red indicates where GoodRx Holdings's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GoodRx Holdings (GDRX) has a FCF Margin % of 33.14% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on GoodRx Holdings and its competitors. This is 113% above median its historical median of 15.54. Over the past decade, GoodRx Holdings' FCF Margin % has ranged from 11.00 to 19.97. According to the industry distribution chart, GoodRx Holdings ranks #67 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 10.1%.
Is GoodRx Holdings' FCF Margin % too high?
GoodRx Holdings' current FCF Margin % of 33.14% is 113% above median its 10-year median of 15.54. Over the past 10 years, this metric has ranged from a low of 11.00 to a high of 19.97. The Healthcare Providers & Services industry median FCF Margin % is 3.03. GoodRx Holdings' value of 33.14% is 995.5% above this industry median. Based on the distribution chart, GoodRx Holdings ranks #67 out of 666 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, GoodRx Holdings has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does GoodRx Holdings' FCF Margin % compare to SDGR and TALK?
According to the Healthcare Providers & Services industry distribution chart, GoodRx Holdings ranks #67 out of 666 companies for FCF Margin %. This places GoodRx Holdings in the top 10% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 3.03. GoodRx Holdings' value of 33.14% is 995.5% above this benchmark. Historically, GoodRx Holdings' own FCF Margin % has ranged from 11.00 to 19.97 over the past decade. While the company's 10-year median is 15.54 vs. the industry median of 3.03, GoodRx Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.03, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. GoodRx Holdings's current FCF Margin % of 33.14% is 995.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on GoodRx Holdings and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GoodRx Holdings's current FCF Margin % is 33.14%, which is 113% above median its own 10-year median of 15.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GoodRx Holdings stock overvalued right now?
Based on GuruFocus' analysis, GoodRx Holdings (GDRX) is currently considered Possible Value Trap. The stock's GF Value™ is $5.29, compared to a current price of $3.67 — trading 30.6% below its estimated fair value. The current FCF Margin % is 33.14%, which is 113% above median its 10-year median of 15.54 and 995.5% above the Healthcare Providers & Services industry median of 3.03. GoodRx Holdings' overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For GoodRx Holdings (GDRX), the current FCF Margin % is 33.14% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GoodRx Holdings (GDRX) Overvalued in 2026?
Based on GuruFocus' analysis, GoodRx Holdings stock appears to be undervalued.
The current stock price of $3.67 is trading 30.6% below its estimated GF Value™ of $5.29.
GuruFocus considers GoodRx Holdings to be Possible Value Trap.
Key valuation signals for GDRX:
FCF Margin %: 33.14% (113% above median its 10-year median of 15.54)
GF Value™: $5.29 vs. price of $3.67 (30.6% below fair value)
Industry Position: 995.5% above the Healthcare Providers & Services median (#67 of 666)
No single metric tells the full story. See the GDRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
70GF Score
Get the complete analysis for GDRX
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GDRX has been successfully added to your 
